Novo’s Wegovy, Ozempic List Price Cuts Reflect Competitive Pressures, Policy Environment

 
• By Cathy Kelly
  
Novo's price reductions will pressure Lilly to respond. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access